Henri MATTES

Person

Brunstatt, FR

People

Patents Grantslast 30 patents

Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 12,168,012
- Issue date Dec 17, 2024
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 12,139,471
- Issue date Nov 12, 2024
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 11,254,653
- Issue date Feb 22, 2022
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
NLRP3 inflammasome inhibitors
- Patent number 11,208,399
- Issue date Dec 28, 2021
- Novartis AG
- Christopher Farady
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1H-quinazoline-2,4-diones processes for their production, pharmaceu...
- Patent number 8,513,268
- Issue date Aug 20, 2013
- Novartis AG
- Hans Allgeier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinazoline derivatives
- Patent number 8,299,085
- Issue date Oct 30, 2012
- Novartis AG
- Hans Allgeier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihyd...
- Patent number 8,012,988
- Issue date Sep 6, 2011
- Novartis AG
- Hans Allgeier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands
- Patent number 7,655,666
- Issue date Feb 2, 2010
- Novartis AG
- Hans Allgeier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine derivatives inhibitors of tyrosine protein kinase SYK
- Patent number 6,589,950
- Issue date Jul 8, 2003
- Novartis AG
- Stephen Paul Collingwood
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Organic compounds
- Patent number 6,177,520
- Issue date Jan 23, 2001
- Novartis AG
- Henri Mattes
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NLRP3 INFLAMMASOME INHIBITORS
- Publication number 20240067627
- Publication date Feb 29, 2024
- Novartis AG
- Xiaobin Ge
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NLRP3 INFLAMMASOME INHIBITORS
- Publication number 20220251067
- Publication date Aug 11, 2022
- Novartis AG
- Christopher FARADY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NLRP3 INFLAMMASOME INHIBITORS
- Publication number 20210308140
- Publication date Oct 7, 2021
- Novartis AG
- Christopher FARADY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NLRP3 INFLAMMASOME INHIBITORS
- Publication number 20200361899
- Publication date Nov 19, 2020
- Novartis AG
- Christopher FARADY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NLRP3 INFLAMMASOME INHIBITORS
- Publication number 20200361898
- Publication date Nov 19, 2020
- Novartis AG
- Christopher FARADY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1H-QUINAZOLINE-2,4-DIONES
- Publication number 20130296332
- Publication date Nov 7, 2013
- Hans Allgeier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1H-QUINAZOLINE-2,4-DIONES
- Publication number 20110294818
- Publication date Dec 1, 2011
- Novartis AG
- Hans ALLGEIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1H-QUINAZ0LINE-2,4-DIONES
- Publication number 20100144747
- Publication date Jun 10, 2010
- Novartis AG
- Hans ALLGEIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1H-Quinazoline-2,4-Diones
- Publication number 20080153836
- Publication date Jun 26, 2008
- Hans Allgeier
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinazoline Derivatives
- Publication number 20070208018
- Publication date Sep 6, 2007
- Novartis AG
- Hans Allgeier
- C07 - ORGANIC CHEMISTRY

Henri MATTES

Person

Patents Grantslast 30 patents

NLRP3 inflammasome inhibitors

NLRP3 inflammasome inhibitors

NLRP3 inflammasome inhibitors

NLRP3 inflammasome inhibitors

1H-quinazoline-2,4-diones processes for their production, pharmaceu...

Quinazoline derivatives

N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihyd...

Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands

Purine derivatives inhibitors of tyrosine protein kinase SYK

Organic compounds

Patents Applicationslast 30 patents

NLRP3 INFLAMMASOME INHIBITORS

NLRP3 INFLAMMASOME INHIBITORS

NLRP3 INFLAMMASOME INHIBITORS

NLRP3 INFLAMMASOME INHIBITORS

NLRP3 INFLAMMASOME INHIBITORS

1H-QUINAZOLINE-2,4-DIONES

1H-QUINAZOLINE-2,4-DIONES

1H-QUINAZ0LINE-2,4-DIONES

1H-Quinazoline-2,4-Diones

Quinazoline Derivatives